2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide

C11H16N4O3 — CID 79410241

IUPAC2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide
SMILESO=C(CN1C[C@@H](O)[C@@H](O)C1)NNc1ccccn1
InChIInChI=1S/C11H16N4O3/c16-8-5-15(6-9(8)17)7-11(18)14-13-10-3-1-2-4-12-10/h1-4,8-9,16-17H,5-7H2,(H,12,13)(H,14,18)/t8-,9+
InChIKeyVUECDCNDTBTNAR-DTORHVGOSA-N
MW252.27 g/mol
LogP-1.44
Rot. Bonds4

About 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide

2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide (PubChem CID 79410241) has the molecular formula C11H16N4O3 and a molecular weight of 252.27 g/mol. Its IUPAC name is 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide.

Molecular Properties

Compound Name2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide
PubChem CID79410241
Molecular FormulaC11H16N4O3
Molecular Weight252.27 g/mol
Exact Mass252.12
IUPAC Name2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide
SMILESO=C(CN1C[C@@H](O)[C@@H](O)C1)NNc1ccccn1
InChIInChI=1S/C11H16N4O3/c16-8-5-15(6-9(8)17)7-11(18)14-13-10-3-1-2-4-12-10/h1-4,8-9,16-17H,5-7H2,(H,12,13)(H,14,18)/t8-,9+
InChIKeyVUECDCNDTBTNAR-DTORHVGOSA-N
XLogP-1.44
TPSA97.72 Ų
H-Bond Donors4
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms18
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500252.27
LogP ≤ 5-1.44
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(3-hydroxyazetidin-1-yl)-N'-pyridin-2-ylacetohydrazide
CID 63282140
2-[4-(2-hydroxyethoxy)piperidin-1-yl]-N'-pyridin-2-ylacetohydrazide
CID 82684328
2-piperidin-1-yl-N-pyridin-2-ylacetamide
CID 12780526
2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N-pyrimidin-2-ylacetamide
CID 79410787
2-[4-(2-aminoethyl)triazol-1-yl]-N'-pyridin-2-ylacetohydrazide
CID 116642304
N-pyridin-2-yl-3-pyrrolidin-1-ylpropanamide
CID 110688245
3-[2-oxo-2-(2-pyridin-2-ylhydrazinyl)ethyl]sulfanylpropanoic acid
CID 43352513
N,N'-dipyridin-2-ylbutanediamide
CID 3684644
4-[2-oxo-2-(pyridin-2-ylamino)ethyl]-N-pyridin-2-ylpiperazine-1-carboxamide
CID 166410262
1-[2-oxo-2-(pyridin-2-ylamino)ethyl]piperidine-4-carboxamide
CID 2917692
N-(2-bromophenyl)-2-(3,4-dihydroxypyrrolidin-1-yl)acetamide
CID 106673025
2-(1-aminopropan-2-ylsulfanyl)-N'-pyridin-2-ylacetohydrazide
CID 66244360

Frequently Asked Questions

What is the IUPAC name of 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide?
The IUPAC name of 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide (CID 79410241) is 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide.
What is the SMILES notation for 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide?
The canonical SMILES for 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide is O=C(CN1C[C@@H](O)[C@@H](O)C1)NNc1ccccn1.
What is the InChIKey of 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide?
The InChIKey is VUECDCNDTBTNAR-DTORHVGOSA-N. The full InChI is InChI=1S/C11H16N4O3/c16-8-5-15(6-9(8)17)7-11(18)14-13-10-3-1-2-4-12-10/h1-4,8-9,16-17H,5-7H2,(H,12,13)(H,14,18)/t8-,9+.
What are the key properties of 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide?
2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide has a molecular weight of 252.27 g/mol, XLogP of -1.44, 4 rotatable bonds, 4 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-N'-pyridin-2-ylacetohydrazide is sourced from PubChem (CID 79410241), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).